# FDA Inspection 709027 - Salix Pharmaceuticals Inc - February 14, 2011

Source: https://www.keypedia.com/records/fda_inspections/salix-pharmaceuticals-inc/724facfd-5f4c-4a37-ae2b-5351db3bb15c
Source feed: FDA_Inspections

> FDA Inspection 709027 for Salix Pharmaceuticals Inc on February 14, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 709027
- Company Name: Salix Pharmaceuticals Inc
- Inspection Date: 2011-02-14
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 917264 - 2015-03-09](https://www.keypedia.com/records/fda_inspections/salix-pharmaceuticals-inc/c8ca7da4-02bd-410a-9597-ce71e695248d)
- [FDA Inspection 783164 - 2012-05-23](https://www.keypedia.com/records/fda_inspections/salix-pharmaceuticals-inc/c8d836cc-7a27-4382-abf9-56bdc568b728)
- [FDA Inspection 683205 - 2010-09-15](https://www.keypedia.com/records/fda_inspections/salix-pharmaceuticals-inc/100d84a5-021c-4b87-9aeb-43e0a1509a58)

Company: https://www.keypedia.com/companies/salix-pharmaceuticals-inc/c29d7f51-1ea9-4878-98b7-5e1bb9c534bf

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c